No significant association between the genetic polymorphisms in the GSK-3β gene and schizophrenia in the Chinese population

Journal of Psychiatric Research

Volumn 42, Issue 5, 2008, Pages 365-370

  Meng, Junwei ^a,b   Shi, Yongyong ^a,b   Zhao, Xinzhi ^a,b   Zhou, Jian ^a,b   Zheng, Yonglan ^b   Tang, Ruqi ^a,b   Ma, Gang ^a,b   Zhu, Xuming ^b   He, Zangdong ^a,b   Wang, Zhe ^a   Xu, Yifeng ^c   Feng, Guoyin ^c   He, Lin ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c SHANGHAI MENTAL HEALTH CENTER   (China)

Author keywords

Case control study; Glycogen synthase kinase 3 (GSK 3 ); Paranoid; Schizophrenia; SNP

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARANOID SCHIZOPHRENIA; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CONTROL GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLYCOGEN SYNTHASE KINASE 3; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; SCHIZOPHRENIA, PARANOID;

EID: 39149109600     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2007.01.005     Document Type: Article

References (35)

1. Badenhop R.F., Moses M.J., Scimone A., Mitchell P.B., Ewen-White K.R., Rosso A., et al. A genome screen of 13 bipolar affective disorder pedigrees provides evidence for susceptibility loci on chromosome 3 as well as chromosomes 9, 13 and 19. Mol Psychiatr 7 (2002) 851-859
2. Bailer U., Leisch F., Meszaros K., Lenzinger E., Willinger U., Strobl R., et al. Genome scan for susceptibility loci for schizophrenia and bipolar disorder. Biol Psychiatr 52 (2002) 40-52
3. Baron M. Genetics of schizophrenia and the new millennium: progress and pitfalls. Am J Hum Genet 68 (2001) 299-312
4. Cannon T.D., Kaprio J., Lonnqvist J., Huttunen M., and Koskenvuo M. The genetic epidemiology of schizophrenia in a Finnish twin cohort. A population-based modeling study. Arch Gen Psychiatr 55 (1998) 67-74
5. Cardno A.G., Marshall E.J., Coid B., Macdonald A.M., Ribchester T.R., Davies N.J., et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psychiatr 56 (1999) 162-168
6. Cardon L.R., and Palmer L.J. Population stratification and spurious allelic association. Lancet 361 (2003) 598-604
7. Colhoun H.M., McKeigue P.M., and Davey Smith G. Problems of reporting genetic associations with complex outcomes. Lancet 361 (2003) 865-872
8. Cotter D., Kerwin R., al-Sarraji S., Brion J.P., Chadwich A., Lovestone S., et al. Abnormalities of Wnt signalling in schizophrenia-evidence for neurodevelopmental abnormality. Neuro Rep 9 (1998) 1379-1383
9. Dudbridge F. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25 (2003) 115-121
10. Emamian E.S., Hall D., Birnbaum M.J., Karayiorgou M., and Gogos J.A. Convergent evidence for impaired AKT1-GSK3β signaling in schizophrenia. Nat Genet 36 (2004) 131-137
11. Hall A.C., Lucas F.R., and Salinas P.C. Axonal remodeling and synaptic differentiation in the cerebellum is regulated by WNT-7a signaling. Cell 100 (2000) 525-535
12. Harrison P.J., and Owen M.J. Genes for schizophrenia? Recent findings and their pathophysiological implications. Lancet 361 (2003) 417-419
13. Ikeda M., Iwata N., Suzuki T., Kitajima T., Yamanouchi Y., Kinoshita Y., et al. No association of GSK3beta gene (GSK3B) with Japanese schizophrenia. Am J Med Genet. Part B, Neuropsychiatr Genet 134 (2005) 90-92
14. Kozlovsky N., Belmaker R.H., and Agam G. GSK-3 and the neurodevelopmental hypothesis of schizophrenia. Eur Neuropsychopharmacol 12 (2002) 13-25
15. Kozlovsky N., Nadri C., and Agam G. Low GSK-3β in schizophrenia as a consequence of neurodevelopmental insult. Eur Neuropsychopharmacol 15 (2005) 1-11
16. Krasilnikov M.A. Phosphatidylinositol-3 kinase dependent pathways: the role in control of cell growth, survival, and malignant transformation. Biochemistry (Mosc) 65 (2000) 59-67
17. Lee K.Y., Ahn Y.M., Joo E.J., Jeong S.H., Chang J.S., Kim S.C., et al. No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population. Neurosci Lett 395 (2006) 175-178
18. Lewis D.A., and Levitt P. Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci 25 (2002) 409-432
19. Lewis D.A., and Lieberman J.A. Catching up on schizophrenia: natural history and neurobiology. Neuron 28 (2000) 325-334
20. Maziade M., Roy M.A., Rouillard E., Bissonnette L., Fournier J.P., Roy A., et al. A search for specific and common susceptibility loci for schizophrenia and bipolar disorder: A linkage study in 13 target chromosomes. Mol Psychiatr 6 (2001) 684-693
21. Maziade M., Roy M.A., Chagnon Y.C., Cliche D., Fournier J.P., Montgrain N., et al. Shared and specific susceptibility loci for schizophrenia and bipolar disorder: a dense genome scan in Eastern Quebec families. Mol Psychiatr 10 (2005) 486-499
22. Nadri C., Lipska B.K., Kozlovsky N., Weinberger D.R., Belmaker R.H., and Agam G. Glycogen synthase kinase (GSK)-3β levels and activity in a neurodevelopmental rat model of schizophrenia. Dev Brain Res 141 (2003) 33-37
23. Patapoutian A., and Reichardt L.F. Roles of Wnt proteins in neural development and maintenance. Curr Opin Neurobiol 10 (2000) 392-399
24. Pei J.J., Braak E., Braak H., Grundke-Iqbal I., Iqbal K., Winblad B., et al. Distribution of active glycogen synthase kinase 3beta (GSK-3beta) in brains staged for Alzheimer disease neurofibrillary changes. J Neuropathol Exp Neurol 58 (1999) 1010-1019
25. Pelech S.L., and Charest D.L. MAP kinase-dependent pathways in cell cycle control. Prog Cell Cycle Res 1 (1995) 33-52
26. Purcell S., Cherny S.S., and Sham P.C. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 19 (2003) 149-150
27. Salinas P.C. Wnt factors in axonal remodelling and synaptogenesis. Biochem Soc Symp 65 (1999) 101-109
28. Scassellati C., Bonvicini C., Perez J., Bocchio-Chiavetto L., Tura G.B., Rossi G., et al. Association study of -1727 A/T, -50 C/T and (CAA)n repeat GSK-3beta gene polymorphisms with schizophrenia. Neuropsychobiology 50 (2004) 16-20
29. Sham P.C., and Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Annu Hum Genet 59 (1995) 97-105
30. Shaw P.C., Davies A.F., Lau K.F., Garcia-Barcelo M., Waye M.M., Lovestone S., et al. Isolation and chromosomal mapping of human glycogen synthase kinase-3 alpha and -3 beta encoding genes. Genome 41 (1998) 720-727
31. Shi Y.Y., and He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 15 (2005) 97-98
32. Szczepankiewicz A., Skibinska M., Hauser J., Slopien A., Leszczynska-Rodziewicz A., Kapelski P., et al. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder. Neuropsychobiology 53 (2005) 51-56
33. van den Oord E.J., and Neale B.M. Will haplotype maps be useful for finding genes?. Mol Psychiatr 9 (2004) 227-236
34. Wall J.D., and Pritchard J.K. Haplotype blocks and linkage disequilibrium in the human genome. Nat Rev Genet 4 (2003) 587-597
35. Woodgett J.R. Molecular cloning and expression of glycogen synthase kinase-3/factor A. EMBO J 9 (1990) 2431-2438